Patents by Inventor Bong Choel KIM

Bong Choel KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING SENSITIVITY TO SIMULTANEOUS INHIBITOR AGAINST PARP AND TANKYRASE
    Publication number: 20200354794
    Abstract: The present invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. According to the present invention, a colorectal treatment effect can be maximized by sorting patients having sensitivity to the simultaneous inhibitor against PARP and Tankyrase.
    Type: Application
    Filed: May 12, 2020
    Publication date: November 12, 2020
    Inventors: Dong Hoon Jin, Seung Woo Hong, Jai Hee Moon, Jae Sik Shin, Seung Mi Kim, Dae Hee Lee, Eun Young Lee, Jung Shin Lee, Bong Choel Kim
  • Method for determining sensitivity to simultaneous inhibitor against PARP and Tankyrase
    Patent number: 10683553
    Abstract: The present invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. According to the present invention, a colorectal treatment effect can be maximized by sorting patients having sensitivity to the simultaneous inhibitor against PARP and Tankyrase.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: June 16, 2020
    Assignee: THE ASAN FOUNDATION
    Inventors: Dong Hoon Jin, Seung Woo Hong, Jai Hee Moon, Jae Sik Shin, Seung Mi Kim, Dae Hee Lee, Eun Young Lee, Jung Shin Lee, Bong Choel Kim
  • METHOD FOR DETERMINING SENSITIVITY TO SIMULTANEOUS INHIBITOR AGAINST PARP AND TANKYRASE
    Publication number: 20180327851
    Abstract: The present invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. According to the present invention, a colorectal treatment effect can be maximized by sorting patients having sensitivity to the simultaneous inhibitor against PARP and Tankyrase.
    Type: Application
    Filed: July 6, 2016
    Publication date: November 15, 2018
    Inventors: Dong Hoon Jin, Seung Woo Hong, Jai Hee Moon, Jae Sik Shin, Seung Mi Kim, Dae Hee Lee, Eun Young Lee, Jung Shin Lee, Bong Choel Kim
  • BIOMARKER FOR PREDICTING THE SENSITIVITY TO A PROTEIN KINASE INHIBITOR AND A USE THEREOF
    Publication number: 20180180616
    Abstract: The present disclosure relates to a biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereof. The present disclosure provides a marker, a composition, and a kit for predicting the sensitivity to a protein kinase inhibitor, and a prediction method thereof. According to the present disclosure, the marker has an excellent effect of predicting the sensitivity to a protein kinase inhibitor, and thus the present disclosure can be useful for cancer treatment.
    Type: Application
    Filed: September 3, 2015
    Publication date: June 28, 2018
    Inventors: Tae Won KIM, Dong Hoon JIN, Seung Woo HONG, Jai Hee MOON, Jae Sik SHIN, Ha Reum LEE, Eun Kyoung CHOI, Seung Mi KIM, Soo A JUNG,, Seung Hee HA, Ha Na JUNG, Dae Hee LEE, Seang Hwan JUNG, Jung Shin LEE, Eun Kyung CHOI, Jae Lyun LEE, Yong Sang HONG, Kyu Pyo KIM, Jeong Eun KIM, Seong Joon PARK, Bong Choel KIM